SOHM Inc. (SHMN) Is ‘One to Watch’
In August 2023, SOHM signed an LOI with CGA Intellectual Holdings Inc. to acquire disruptive stem cell technology and patents…
Blog
D-Wave Quantum Inc. (NYSE: QBTS) Announces Third-Quarter Financial Highlights, Voices Support for Expanded National Quantum Initiative
D-Wave third-quarter revenue grew by 51% year-over-year D-Wave’s third quarter bookings increased by 53% year-over-year, representing the company’s sixth consecutive…
Software Effective Solutions Corp. (SFWJ) Is ‘One to Watch’
MedCana announced in May 2023 full-scale production of non-THC cannabis for export to Europe The company earlier in 2023 commenced…
QualityStocksNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview
Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short…
QualityStocksNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Issues Warning to Shareholders
Safety Shot (NASDAQ: SHOT) today announced that it has come to its attention that there are several disclosed short sellers…
QualityStocksNewsBreaks – Electronic Servitor Publication Network Inc. (XESP) Helping Modern Businesses Navigate Ever-Evolving Digital Space
Electronic Servitor Publication Network (OTC: XESP), focused on disrupting the market for B2B companies by driving better digital interactions and…
QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Updated Safety Data from Berubicin Study at SNO Annual Gathering
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in…
Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA, Presented Data at Two October Events Focused on Lung Cancer
Genprex was granted orphan drug designation by the FDA earlier this year for development of REQORSA combined with Tecentriq in…
Clene Inc. (NASDAQ: CLNN) Capitalizing on the Promising Chemical and Therapeutic Properties of Nanocrystals to Address High Unmet Medical Needs
Clene is focused on developing and commercializing novel clean-surfaced nanotechnology (“CSN(R)”) therapeutics The company utilizes an electro-crystallization nanotherapeutics platform, which…
QualityStocksNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Poised to Spearhead Advancements in Battle Against Diseases, Harness Cutting-Edge AI Technology
Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy, recently announced a definitive agreement to…